Literature DB >> 36221946

Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios Are Associated with Recurrent Ischemic Stroke in Patients with Embolic Stroke of Undetermined Source.

Tony Y W Li1, Ching-Hui Sia1,2, Bernard P L Chan3, Jamie S Y Ho4, Aloysius S Leow5, Mark Y Chan1,2, Pipin Kojodjojo1,2, Mary Joyce Galupo1, Hock-Luen Teoh3, Vijay K Sharma2,3, Raymond C S Seet2,3, Leonard L L Yeo2,3, Benjamin Yong-Qiang Tan2,3.   

Abstract

Entities:  

Year:  2022        PMID： 36221946      PMCID： PMC9561212          DOI： 10.5853/jos.2022.00486

Source DB:  PubMed          Journal:  J Stroke        ISSN： 2287-6391            Impact factor:   8.632


× No keyword cloud information.
  10 in total

1.  The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict left ventricular thrombus resolution in acute myocardial infarction without percutaneous coronary intervention.

Authors:  Ching-Hui Sia; Aloysius Sheng-Ting Leow; Benjamin Yong-Qiang Tan; Christopher Junyan Low; Rajinderdeep Kaur; Tiong-Cheng Yeo; Mark Yan-Yee Chan; Edgar Lik-Wui Tay; Leonard Leong-Litt Yeo; Eng-Soo Yap; Joshua Ping-Yun Loh
Journal:  Thromb Res       Date:  2020-06-03       Impact factor: 3.944

Review 2.  Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update.

Authors:  Robert G Hart; Luciana Catanese; Kanjana S Perera; George Ntaios; Stuart J Connolly
Journal:  Stroke       Date:  2017-03-06       Impact factor: 7.914

Review 3.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03       Impact factor: 6.875

4.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

Review 5.  Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis.

Authors:  Luciano A Sposato; Lauren E Cipriano; Gustavo Saposnik; Estefanía Ruíz Vargas; Patricia M Riccio; Vladimir Hachinski
Journal:  Lancet Neurol       Date:  2015-03-04       Impact factor: 44.182

6.  Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

Authors:  Jean-Claude Tardif; Simon Kouz; David D Waters; Olivier F Bertrand; Rafael Diaz; Aldo P Maggioni; Fausto J Pinto; Reda Ibrahim; Habib Gamra; Ghassan S Kiwan; Colin Berry; José López-Sendón; Petr Ostadal; Wolfgang Koenig; Denis Angoulvant; Jean C Grégoire; Marc-André Lavoie; Marie-Pierre Dubé; David Rhainds; Mylène Provencher; Lucie Blondeau; Andreas Orfanos; Philippe L L'Allier; Marie-Claude Guertin; François Roubille
Journal:  N Engl J Med       Date:  2019-11-16       Impact factor: 91.245

Review 7.  Anti-inflammatory therapeutics for the treatment of atherosclerosis.

Authors:  Israel F Charo; Rebecca Taub
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694

8.  Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

Authors:  Hans-Christoph Diener; Ralph L Sacco; J Donald Easton; Christopher B Granger; Richard A Bernstein; Shinichiro Uchiyama; Jörg Kreuzer; Lisa Cronin; Daniel Cotton; Claudia Grauer; Martina Brueckmann; Marina Chernyatina; Geoffrey Donnan; José M Ferro; Martin Grond; Bernd Kallmünzer; Jerzy Krupinski; Byung-Chul Lee; Robin Lemmens; Jaime Masjuan; Miroslav Odinak; Jeffrey L Saver; Peter D Schellinger; Danilo Toni; Kazunori Toyoda
Journal:  N Engl J Med       Date:  2019-05-16       Impact factor: 91.245

9.  Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.

Authors:  Robert G Hart; Mukul Sharma; Hardi Mundl; Scott E Kasner; Shrikant I Bangdiwala; Scott D Berkowitz; Balakumar Swaminathan; Pablo Lavados; Yongjun Wang; Yilong Wang; Antonio Davalos; Nikolay Shamalov; Robert Mikulik; Luis Cunha; Arne Lindgren; Antonio Arauz; Wilfried Lang; Anna Czlonkowska; Jens Eckstein; Rubens J Gagliardi; Pierre Amarenco; Sebastian F Ameriso; Turgut Tatlisumak; Roland Veltkamp; Graeme J Hankey; Danilo Toni; Daniel Bereczki; Shinichiro Uchiyama; George Ntaios; Byung-Woo Yoon; Raf Brouns; Matthias Endres; Keith W Muir; Natan Bornstein; Serefnur Ozturk; Martin J O'Donnell; Matthys M De Vries Basson; Guillaume Pare; Calin Pater; Bodo Kirsch; Patrick Sheridan; Gary Peters; Jeffrey I Weitz; W Frank Peacock; Ashkan Shoamanesh; Oscar R Benavente; Campbell Joyner; Ellison Themeles; Stuart J Connolly
Journal:  N Engl J Med       Date:  2018-05-16       Impact factor: 91.245

10.  Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis.

Authors:  Andrea Artoni; Maria Abbattista; Paolo Bucciarelli; Francesca Gianniello; Erica Scalambrino; Emanuela Pappalardo; Flora Peyvandi; Ida Martinelli
Journal:  Clin Appl Thromb Hemost       Date:  2017-10-31       Impact factor: 2.389
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.